Patents expiring in 2036

US 9346880

Stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9347054

Polymer factor IX moiety conjugates

Nektar Therapeutics · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9346859

Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9346867

Cancer-related glycopeptide epitopes, antibodies and methods of use

SUMITOMO BAKELITE CO., LTD. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9346865

Antimicrobial peptides and methods of use

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9347062

Interfering RNA delivery system and uses thereof

Arrowhead Research Corporation · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9347143

Membrane template synthesis of microtube engines

The Regents of the University of California · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9347063

Oligonucleotide analog and method for treating flavivirus infections

Sarepta Therapeutics, Inc. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9346866

Inhibition of tace activity with cyclic peptides

The Regents of the University of California · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9345780

Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

Tekmira Pharmaceuticals Corporation · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9346746

R(+)-N-formyl-propargyl-aminoindan

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9347951

Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

PH 12016500580

CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

OXFORD BIOTHERAPEUTICS LTD [GB] · Granted Mon May 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Sun May 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9352027

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353107

3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors

Aurigene Discovery Technologies Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353352

Embryonic stem cell specific microRNAs promote induced pluripotency

The Regents of the University of California · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351962

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351964

Methods for treating cancer and non-neoplastic conditions

PTC THERAPEUTICS, INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351490

Selectively targeted antimicrobial peptides and the use thereof

The Regents of the University of California · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351960

Agent for the treatment of viral hepatitis C

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9352048

Carbohydrate conjugates as delivery agents for oligonucleotides

Alnylam Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351997

Method of treating cancer

Intensity Therapeutics, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351975

Modified release preparations containing oxcarbazepine and derivatives thereof

Supernus Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351968

Methods of treating developmental disorders using pipradrol

OVID THERAPEUTICS INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351989

Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections

University College Cardiff Consultants Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351984

Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

The Board of Regents of the University of Texas System · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9352032

Live attenuated antigenically marked classical swine fever vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9352019

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

University of Connecticut Health Center · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353069

Super-oxide dismutase mimetics

Galera Labs, LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353175

Use of antagonists targeting metallothionein to treat intestinal inflammation

UNIVERSITY OF CONNECTICUT · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353111

Carboxamide compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353108

Tetrahydronaphthyridine somatostatin receptor 5 antagonists

Takeda Pharmaceutical Company Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353117

Substituted pyrazolopyrimidines as glucocerebrosidase activators

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9352011

Method and composition for synchronizing time of insemination

JBS United Animal Health II LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353106

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

Theravance Biopharma R&D IP, LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353126

Substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353163

Apelin fusion proteins and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351954

Multicyclic compounds and methods of use thereof

PGI Drug Discovery LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353094

Substituted quinoxalines as kinase inhibitors

The Board of Regents of the University of Texas System · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353353

Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353178

Stem cell factor inhibitor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353240

Elastomer formulations comprising discrete carbon nanotube fibers

MOLECULAR REBAR DESIGN, LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353372

Compositions and their uses directed to huntingtin

Ionis Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353112

Synthesis of polycyclic alkaloids

Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353124

Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9351970

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353176

Method of treating osteoarthritis with an antibody to NGF

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9353075

Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)

The Regents of the University of California · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)